Expression of bcl-2 protein in lymphocytes of patients with laryngeal carcinoma
✍ Scribed by J. Klatka; J. Roliński; K. Kupisz; S. Klonowski; D. Skomra
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 278 KB
- Volume
- 256
- Category
- Article
- ISSN
- 0302-9530
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We investigated immunohistochemically the clinical relevance of the over-expression of the apoptosis-regulating proteins p53 and bcl-2 in a homogeneous series of 149 laryngeal squamous-cell carcinomas. p53 was over-expressed in 75 cases and bcl-2 in 39 cases. p53 and bcl-2 co-expression was found in
Bcl-2 protein inhibits apoptosis, reduces the requirement for growth factors, and thereby extends the survival of cells. Recent findings of Bcl-2 in several solid tumors suggest that it might contribute to the genesis of some types of cancer. Over-expression of Bcl-2 might play a role in carcinogene
## Background: Bcl-2 and bax genes are known to be involved in the control of apoptotic cell death, an important mechanism of growth regulation that influences the biologic behavior of tumors. the aim of the current study was to investigate the relationship of bcl-2 and bax expression to the rate o
## Abstract ## Background Proteins regulating the cell cycle and cell death are frequently abnormally expressed in cancer. Several of these, particularly p53 and Bcl‐2, have been widely suggested as possible prognostic markers in diverse human malignancies. Their role in predicting outcome in squa
The bcl-2 oncogene has been involved in the genesis of various B-cell neoplasms by means of encoding for p26, an apoptosis suppressor oncoprotein. The expression of p26 in lymphoproliferative disorders of large granular lymphocytes (LDLGL), a group of diseases whose mechanism leading to lymphocyte e